34 publications found

Export from record to in Excel or PDF
  • 2017
    *Cho M. , *Cervadoro A.iit , *Ramirez M.R. , *Stigliano C. , *Brazdeikis A. , *Colvin V.L. , *Civera P. , *Key J. , *Decuzzi P.iit

    Assembly of iron oxide nanocubes for enhanced cancer hyperthermia and magnetic resonance imaging

    Nanomaterials, vol. 7, (no. 4)
    Article
  • 2017
    Palange A.L.iit , Palomba R.iit , Rizzuti I.F.iit , Ferreira M.iit , *Decuzzi P.iit

    Deformable Discoidal Polymeric Nanoconstructs for the Precise Delivery of Therapeutic and Imaging Agents

    Molecular Therapy, vol. 25, (no. 7), pp. 1514-1521
    Review
  • 2017
    Lee A.iit , De Mei C.iit , Fereira M.iit , Marotta R.iit , Yoon H.Y. , Kim K. , Kwon I.C. , *Decuzzi P.iit

    Dexamethasone-loaded polymeric nanoconstructs for monitoring and treating inflammatory bowel disease

    Theranostics, vol. 7, (no. 15), pp. 3653-3666
    Article
  • 2017
    Anchordoquy T.J. , Barenholz Y. , Boraschi D. , Chorny M. , Decuzzi P.iit , Dobrovolskaia M.A.iit , Farhangrazi Z.S. , Farrell D. , Gabizon A. , Ghandehari H. , Godin B. , La-Beck N.M. , Ljubimova J. , Moghimi S.M. , Pagliaro L. , Park J.-H. , Peer D. , Ruoslahti E. , Serkova N.J. , *Simberg D.

    Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions

    ACS Nano, vol. 11, (no. 1), pp. 12-18
    Review
  • 2017
    Stigliano C. , Ramirez M.R. , Singh J.V. , Aryal S. , Key J. , Blanco E. , *Decuzzi P.iit

    Methotraxate-Loaded Hybrid Nanoconstructs Target Vascular Lesions and Inhibit Atherosclerosis Progression in ApoE−/− Mice

    Advanced healthcare materials, vol. 6, (no. 13)
    Article
  • 2017
    *Boraschi D. , Italiani P. , Palomba R.iit , Decuzzi P.iit , Duschl A. , Fadeel B. , Moghimi S.M.

    Nanoparticles and innate immunity: new perspectives on host defence

    Seminars in Immunology, vol. 34, pp. 33-51
    Review
  • 2017
    Coclite A.iit , Mollica H.iit , Ranaldo S. , Pascazio G. , de Tullio M.D. , *Decuzzi P.iit

    Predicting different adhesive regimens of circulating particles at blood capillary walls

    Microfluidics and Nanofluidics, vol. 21, (no. 11)
    Article
  • 2016
    Coclite A.iit , de Tullio M. D. , Pascazio G. , Decuzzi P.

    A combined Lattice Boltzmann and Immersed boundary approach for predicting the vascular transport of differently shaped particles

    Computers and Fluids, vol. 136, pp. 260-271
    Article
  • 2016
    *Coclite A.iit , *de Tullio M.D. , *Pascazio G. , *Decuzzi P.iit

    A combined Lattice Boltzmann and Immersed boundary approach for predicting the vascular transport of differently shaped particles

    Computers and Fluids, vol. 136, pp. 260-271
    Article
  • 2016
    Manneschi C.iit , Pereira R.C.iit , Marinaro G.iit , Bosca A.iit , Francardi M.iit , *Decuzzi P.iit

    A microfluidic platform with permeable walls for the analysis of vascular and extravascular mass transport

    Microfluidics and Nanofluidics, vol. 20, (no. 8)
    Article
  • 2016
    *Mascheroni P. , *Boso D.P. , *Stigliano C. , *Carfagna M. , *Preziosi L. , *Decuzzi P.iit , *Schrefler B.A.

    A parametric study of a multiphase porous media model for tumor spheroids and environment interactions

    ECCOMAS Congress 2016 - Proceedings of the 7th European Congress on Computational Methods in Applied Sciences and Engineering, vol. 1, pp. 178-187
    Conference Paper
  • 2016
    Iodice C. , Cervadoro A. , Palange A. , Key J. , Aryal S. , Ramirez M.R. , Mattu C. , Ciardelli G. , O'Neill B.E. , *Decuzzi P.iit

    Enhancing photothermal cancer therapy by clustering gold nanoparticles into spherical polymeric nanoconstructs

    Optics and Lasers in Engineering, vol. 76, pp. 74-81
    Article
  • 2016
    *Decuzzi P.iit

    Facilitating the Clinical Integration of Nanomedicines: The Roles of Theoretical and Computational Scientists

    ACS Nano, vol. 10, (no. 9), pp. 8133-8138
    Article
  • 2016
    *Pereira R.C.iit , Martinelli D. , Cancedda R. , Gentili C. , *Poggi A.

    Human articular chondrocytes regulate immune response by affecting directly T cell proliferation and indirectly inhibiting monocyte differentiation to professional antigen-presenting cells

    Frontiers in Immunology, vol. 7, (no. OCT)
    Article
  • 2016
    *Key J. , Dhawan D. , Cooper C.L. , Knapp D.W. , Kim K. , Kwon I.C. , Choi K. , Park K. , Decuzzi P.iit , Leary J.F.

    Multicomponent, peptide-targeted glycol chitosan nanoparticles containing ferrimagnetic iron oxide nanocubes for bladder cancer multimodal imaging

    International journal of nanomedicine, vol. 11, pp. 4141-4155
    Article
  • 2016
    *Ciardelli G. , *Decuzzi P.iit

    Nanomedicine Advancing from Bench to Bedside: The Role of Polymeric Materials

    Polymer International, vol. 65, (no. 7), pp. 733-733
    Editorial
  • 2016
    *Pereira R.C.iit , Gentili C. , Cancedda R. , Decuzzi P.iit

    New perspectives in cartilage medicine: Latest biology insights can redirect future cartilage medical strategies?

    Biology and Medicine, vol. 8, (no. 6)
    Note
  • 2016
    Marianecci C. , Di Marzio L. , Del Favero E. , Cantu L. , Brocca P. , Rondelli V. , Rinaldi F.iit , Dini L. , Serra A. , Decuzzi P.iit , Celia C. , Paolino D. , Fresta M. , *Carafa M.

    Niosomes as Drug Nanovectors: Multiscale pH-Dependent Structural Response

    Langmuir, vol. 32, (no. 5), pp. 1241-1249
    Article
  • 2016
    *Aryal S. , Stigliano C. , Key J. , Ramirez M. , Anderson J. , Karmonik C. , Fung S. , *Decuzzi P.iit

    Paramagnetic Gd3+ labeled red blood cells for magnetic resonance angiography

    Biomaterials, vol. 98, pp. 163-170
    Article
  • 2016
    *Mascheroni P. , Stigliano C. , Carfagna M. , Boso D.P. , Preziosi L. , Decuzzi P.iit , Schrefler B.A.

    Predicting the growth of glioblastoma multiforme spheroids using a multiphase porous media model

    Biomechanics and Modeling in Mechanobiology, vol. 15, (no. 5), pp. 1215-1228
    Article

INFORMATION NOTICE ON COOKIES

IIT's website uses the following types of cookies: browsing/session, analytics, functional and third party cookies. Users can choose whether or not to accept the use of cookies and access the website.
By clicking on further information, the full information notice on the types of cookies used will be displayed and you will be able to choose whether or not to accept cookies whilst browsing on the website.
Further information
Accept and close

I numeri di IIT

L’Istituto Italiano di Tecnologia (IIT) è una fondazione di diritto privato - cfr. determinazione Corte dei Conti 23/2015 “IIT è una fondazione da inquadrare fra gli organismi di diritto pubblico con la scelta di un modello di organizzazione di diritto privato per rispondere all’esigenza di assicurare procedure più snelle nella selezione non solo nell’ambito nazionale dei collaboratori, scienziati e ricercatori ”.

IIT è sotto la vigilanza del Ministero dell'Istruzione, dell'Università e della Ricerca e del Ministero dell'Economia e delle Finanze ed è stato istituito con la Legge 326/2003. La Fondazione ha l'obiettivo di promuovere l'eccellenza nella ricerca di base e in quella applicata e di favorire lo sviluppo del sistema economico nazionale. La costruzione dei laboratori iniziata nel 2006 si è conclusa nel 2009.

Lo staff complessivo di IIT conta circa 1440 persone. L’area scientifica è rappresentata da circa l’85% del personale. Il 45% dei ricercatori proviene dall’estero: di questi, il 29% è costituito da stranieri provenienti da oltre 50 Paesi e il 16% da italiani rientrati. Oggi il personale scientifico è composto da circa 60 principal investigators, circa 110 ricercatori e tecnologi di staff, circa 350 post doc, circa 500 studenti di dottorato e borsisti, circa 130 tecnici. Oltre 330 posti su 1400 creati su fondi esterni. Età media 34 anni. 41% donne / 59 % uomini.

Nel 2015 IIT ha ricevuto finanziamenti pubblici per circa 96 milioni di euro (80% del budget), conseguendo fondi esterni per 22 milioni di euro (20% budget) provenienti da 18 progetti europei17 finanziamenti da istituzioni nazionali e internazionali, circa 60 progetti industriali

La produzione di IIT ad oggi vanta circa 6990 pubblicazioni, oltre 130 finanziamenti Europei e 11 ERC, più di 350 domande di brevetto attive, oltre 12 start up costituite e altrettante in fase di lancio. Dal 2009 l’attività scientifica è stata ulteriormente rafforzata con la creazione di dieci centri di ricerca nel territorio nazionale (a Torino, Milano, Trento, Parma, Roma, Pisa, Napoli, Lecce, Ferrara) e internazionale (MIT ed Harvard negli USA) che, unitamente al Laboratorio Centrale di Genova, sviluppano i programmi di ricerca del piano scientifico 2015-2017.

IIT: the numbers

Istituto Italiano di Tecnologia (IIT) is a public research institute that adopts the organizational model of a private law foundation. IIT is overseen by Ministero dell'Istruzione, dell'Università e della Ricerca and Ministero dell'Economia e delle Finanze (the Italian Ministries of Education, Economy and Finance).  The Institute was set up according to Italian law 326/2003 with the objective of promoting excellence in basic and applied research andfostering Italy’s economic development. Construction of the Laboratories started in 2006 and finished in 2009.

IIT has an overall staff of about 1,440 people. The scientific staff covers about 85% of the total. Out of 45% of researchers coming from abroad 29% are foreigners coming from more than 50 countries and 16% are returned Italians. The scientific staff currently consists of approximately 60 Principal Investigators110 researchers and technologists350 post-docs and 500 PhD students and grant holders and 130 technicians. External funding has allowed the creation of more than 330 positions . The average age is 34 and the gender balance proportion  is 41% female against 59% male.

In 2015 IIT received 96 million euros in public funding (accounting for 80% of its budget) and obtained 22 million euros in external funding (accounting for 20% of its budget). External funding comes from 18 European Projects, other 17 national and international competitive projects and approximately 60 industrial projects.

So far IIT accounts for: about 6990 publications, more than 130 European grants and 11 ERC grants, more than 350 patents or patent applications12 up start-ups and as many  which are about to be launched. The Institute’s scientific activity has been further strengthened since 2009 with the establishment of 11 research nodes throughout Italy (Torino, Milano, Trento, Parma, Roma, Pisa, Napoli, Lecce, Ferrara) and abroad (MIT and Harvard University, USA), which, along with the Genoa-based Central Lab, implement the research programs included in the 2015-2017 Strategic Plan.